PGHL logo

Procter & Gamble Health L

PGHL·NSE·
5,751.50 -16.50 (-0.29%)
Market Cap9590.49 Cr
PE Ratio29.20
Volume8,087
Day High - Low5825.00 - 5663.50
52W High-Low6975.00 - 4707.00
DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
62.29%
Strong
P/E
29.20x
Fair
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day5664
5825
52W4707
6975
DocStoX take

Supported by quality (9.5) and risk (9.2), but held back by valuation (2.4). Quality looks strong at 9.5, but that is offset by valuation at 2.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.5
/10
Fair
Quality
Excellent
ROE 62.3%
Valuation
Expensive
P/E 29.2×
Growth
Steady
Revenue +6.9% 5Y CAGR
Risk
Low risk
D/E 0.02
Momentum
Soft
46% of 52-week range

At a glance

Market Cap
₹9,590 Cr
52W High / Low
₹6975 / ₹4707
Dividend Yield
3.58%
Promoter Holding
51.82%
EPS (TTM)
₹196.94
Book Value
₹316.19

Key highlights

  • Capital works hard — ROCE 84%
  • Strong returns on equity (62%)
  • Low leverage — D/E 0.02
  • Valuation is weak (2.4/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

PROCTER & GAMBLE HEALTH L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.